Block Listing Update

RNS Number : 6852F

Futura Medical PLC

28 April 2014

 

For immediate release

28 April 2014

Futura Medical plc

("Futura" or "the Company")

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, in the six months since the previous block admission update in October 2013 the following changes have taken place:

Futura Medical plc Option Plan	Block Listed  2011-2013	Block Listing Brought Forward	Options Exercised in Period	Re-classified	Block Listing Carried Forward
Unapproved Share Option Scheme	2,008,383	1,878,114	(100,000)	8,321	1,786,435
EMI Share Option Scheme	2,996,617	1,889,127	(52,500)	(8,321)	1,828,306
	5,005,000	3,767,241	(152,500)	-	3,614,741

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nominated Adviser:
N+1 Singer Aubrey Powell / Joe Stroud	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

BLRPGUAPCUPCGCR